Subcortical volumetric abnormalities in bipolar disorder

Molecular Psychiatry

Volumn 21, Issue 12, 2016, Pages 1710-1716

  Hibar, D P ^a   Westlye, L T ^b,c   Van Erp, T G M ^d   Rasmussen, J ^d   Leonardo, C D ^a   Faskowitz, J ^a   Haukvik, U K ^b,e   Hartberg, C B ^b   Doan, N T ^b   Agartz, I ^b,e   Dale, A M ^f,g   Gruber, O ^h,i   Kramer B ^h   Trost, S ^h   Liberg, B ^j   Abe C ^j   Ekman, C J ^j   Ingvar, M ^j,k   Landen M ^j,l   Fears, S C ^m,n   Freimer, N B ⁿ   Bearden, C E ^m,n   Sprooten, E ^o,p   Glahn, D C ^o,p   Pearlson, G D ^o,p   Emsell, L ^q   Kenney, J ^q   Scanlon, C ^q   McDonald, C ^q   Cannon, D M ^q   Almeida, J ^r   Versace, A ^s   Caseras, X ^t   Lawrence, N S ^u   Phillips, M L ^t   Dima, D ^v,w   Delvecchio, G ^v   Frangou, S ^w   Satterthwaite, T D ^x   Wolf, D ^x   Houenou, J ^y,z   Henry, C ^z,aa   Malt, U F ^b,c,ab   BOen E ^c,e,ab,ac   Elvs'shagen, T ^b,c,ab   Young, A H ^v   Lloyd, A J ^ad   Goodwin, G M ^ae   Mackay, C E ^ae   Bourne, C ^ae,af   Bilderbeck, A ^ae   Abramovic, L ^ag   Boks, M P ^ag   Van Haren, N E M ^ag   Ophoff, R A ^n,ag   Kahn, R S ^ag   Bauer, M ^ah   Pfennig, A ^ah   Alda, M ^ai   Hajek, T ^ai,aj   Mwangi, B ^ak   Soares, J C ^ak   Nickson, T ^al   Dimitrova, R ^al   Sussmann, J E ^al   Hagenaars, S ^al   Whalley, H C ^al   McIntosh, A M ^al   Thompson, P M ^a,n   Andreassen, O A ^b   more..

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DIAKONHJEMMET HOSPITAL   (Norway)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^j KAROLINSKA INSTITUTE   (Sweden)

^k KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^l UNIVERSITY OF GOTHENBURG   (Sweden)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p INSTITUTE OF LIVING   (United States)

^q NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^r BROWN UNIVERSITY   (United States)

^s UNIVERSITY OF PITTSBURGH   (United States)

^t CARDIFF UNIVERSITY   (United Kingdom)

^u UNIVERSITY OF EXETER   (United Kingdom)

^v KING'S COLLEGE LONDON   (United Kingdom)

^w MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY OF PENNSYLVANIA   (United States)

^y CEA SACLAY   (France)

^z INSERM U955   (France)

^aa UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^ab OSLO UNIVERSITY HOSPITAL   (Norway)

^ac Norwegian Research Network on Mood Disorders (NORMOOD)   (Norway)

^ad NEWCASTLE UNIVERSITY   (United Kingdom)

^ae UNIVERSITY OF OXFORD   (United Kingdom)

^af NEWMAN UNIVERSITY   (United Kingdom)

^ag UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^ah UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^ai DALHOUSIE UNIVERSITY   (Canada)

^aj NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^ak UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^al UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM; NEUROLEPTIC AGENT;

AMYGDALA; ANTICONVULSANT THERAPY; ARTICLE; BIPOLAR DISORDER; BRAIN SIZE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUTAMEN; QUANTITATIVE ANALYSIS; SUBCORTEX; THALAMUS; ADULT; ANATOMY AND HISTOLOGY; BRAIN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; BIPOLAR DISORDER; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; RETROSPECTIVE STUDIES;

EID: 84995699210     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2015.227     Document Type: Article

References (51)

1. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251
2. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 2003; 60: 497-502
3. McDonald C, Zanelli J, Rabe-Hesketh S, Ellison-Wright I, Sham P, Kalidindi S, et al. Meta-analysis of magnetic resonance imaging brain morphometry studies in bipolar disorder. Biol Psychiatry 2004; 56: 411-417
4. Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry 2008; 65: 1017-1032
5. Arnone D, Cavanagh J, Gerber D, Lawrie SM, Ebmeier KP, McIntosh AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry 2009; 195: 194-201
6. Dickstein DP, Milham MP, Nugent AC, Drevets WC, Charney DS, Pine DS, et al. Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study. Arch Gen Psychiatry 2005; 62: 734-741
7. Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, et al. Age, rapidcycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 2006; 59: 611-618
8. Gogtay N, Ordonez A, Herman DH, Hayashi KM, Greenstein D, Vaituzis C, et al. Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness. J Child Psychol Psyc 2007; 48: 852-862
9. Hallahan B, Newell J, Soares JC, Brambilla P, Strakowski SM, Fleck DE, et al. Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data. Biol Psychiatry 2011; 69: 326-335
10. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Menji HK. Lithium-induced increase in human brain grey matter. Lancet 2000; 356: 1241-1242
11. Hajek T, Kopecek M, Hoschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci 2012; 37: 333-343
12. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 2012; 44: 552-561
13. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645
14. Glahn DC, Thompson PM, Blangero J. Neuroimaging endophenotypes: strategies for finding genes influencing brain structure and function. Hum Brain Mapp 2007; 28: 488-501
15. Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage 2002; 16: 331-348
16. Chen CH, Suckling J, Lennox BR, Ooi C, Bullmore ET. A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 2011; 13: 1-15
17. Kalmar JH, Wang F, Chepenik LG, Womer FY, Jones MM, Pittman B, et al. Relation between amygdala structure and function in adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2009; 48: 636-642
18. Morey RA, Selgrade ES, Wagner HR 2nd, Huettel SA, Wang L, McCarthy G. Scanrescan reliability of subcortical brain volumes derived from automated segmentation. Hum Brain Mapp 2010; 31: 1751-1762
19. Hibar DP, Stein JL, Renteria ME, Arias-Vasquez A, Desrivieres S, Jahanshad N, et al. Common genetic variants influence human subcortical brain structures. Nature 2015; 520: 224-229
20. Strakowski SM, Adler CM, Almeida J, Altshuler LL, Blumberg HP, Chang KKD, et al. The functional neuroanatomy of bipolar disorder: a consensus model. Bipolar Disord 2012; 14: 313-325
21. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. (vol 82, pg 591, 2007). Biol Rev Camb Philos Soc 2009; 84: 515
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300
23. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler DJ, Pung CJ, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry 2010; 68: 41-50
24. Fears SC, Service SK, Kremeyer B, Araya C, Araya X, Bejarano J, et al. Multisystem component phenotypes of bipolar disorder for genetic investigations of extended pedigrees. JAMA Psychiatry 2014; 71: 375-387
25. Altshuler LL, Bartzokis G, Grieder T, Curran J, Jimenez T, Leight K, et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry 2000; 48: 147-162
26. Chang K, Karchemskiy A, Barnea-Goraly N, Garrett A, Simeonova DI, Reiss A. Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005; 44: 565-573
27. Pfeifer JC, Welge J, Strakowski SM, Adler CM, DelBello MP. Meta-analysis of amygdala volumes in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2008; 47: 1289-1298
28. Bitter SM, Mills NP, Adler CM, Strakowski SM, DelBello MP. Progression of amygdala volumetric abnormalities in adolescents after their first manic episode. J Am Acad Child Adolesc Psychiatry 2011; 50: 1017-1026
29. Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K. Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013; 37: 418-435
30. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, McCloskey S, Grof P. The developmental trajectory of bipolar disorder. Br J Psychiatry 2014; 204: 122-128
31. van Erp TGM, Hibar DP, Rasmussen JM, Glahn DC, Pearlson GD, Andreassen OA, et al. Subcortical brain volume abnormalities in 2,028 patients with schizophrenia and 2,540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2015. doi: 10.1038/mp.2015.63
32. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57: 925-935
33. Webster MJ, Knable MB, O'Grady J, Orthmann J, Weickert CS. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry 2002; 7: 924
34. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children's selfreported psychotic symptoms and adult schizophreniform disorder -A 15-year longitudinal study. Arch Gen Psychiatry 2000; 57: 1053-1058
35. Reichenberg A, Caspi A, Harrington H, Houts R, Keefe RSE, Murray RM, et al. Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry 2010; 167: 160-169
36. Schmaal L, Veltman DJ, van Erp TGM, Sämann PG, Frodl T, Jahanshad N, et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol Psychiatry 2015. doi: 10.1038/mp.2015.69
37. Tesli M, Espeseth T, Bettella F, Mattingsdal M, Aas M, Melle I, et al. Polygenic risk score and the psychosis continuum model. Acta Psychiatry Scand 2014; 130: 311-317
38. Yucel K, McKinnon MC, Taylor VH, Macdonald K, Alda M, Young LT, et al. Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study. Psychopharmacology 2007; 195: 357-367
39. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 2010; 35: 1743-1750
40. Cadotte DW, Xu B, Racine RJ, MacQueen GM, Wang JF, McEwen B, et al. Chronic lithium treatment inhibits pilocarpine-induced Mossy fiber sprouting in rat hippocampus. Neuropsychopharmacology 2003; 28: 1448-1453
41. Bachmann RF, Schloesser RJ, Gould TD, Manji HK. Mood stabilizers target cellular plasticity and resilience cascades -Implications for the development of novel therapeutics. Mol Neurobiol 2005; 32: 173-202
42. Frey BN, Andreazza AC, Cereser KMM, Martins MR, Valvassori SS, Reus GZ, et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci 2006; 79: 281-286
43. Hajek T, Bauer M, Simhandl C, Rybakowski J, O'Donovan C, Pfennig A, et al. Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response. Psychol Med 2014; 44: 507-517
44. Hajek T, Cullis J, Novak T, Kopecek M, Hoschl C, Blagdon R, et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord 2012; 14: 261-270
45. Phillips ML, Travis MJ, Fagiolini A, Kupfer DJ. Medication effects in neuroimaging studies of bipolar disorder. Am J Psychiatry 2008; 165: 313-320
46. Jernigan TL, Butters N, Ditraglia G, Schafer K, Smith T, Riwin M, et al. Reduced cerebral gray-matter observed in alcoholics using magnetic-resonance-imaging. Alcohol Clin Exp Res 1991; 15: 418-427
47. Ledoux JE. Emotion -clues from the Brain. Annu Rev Psychol 1995; 46: 209-235
48. Phillips M, Ladouceur C, Drevets W. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13: 833-857
49. Chen CH, Lennox B, Jacob R, Calder A, Lupson V, Bisbrown-Chippendale R, et al. Explicit and implicit facial affect recognition in manic and depressed states of bipolar disorder: A functional magnetic resonance imaging study. Biol Psychiatry 2006; 59: 31-39
50. Torrey EF, Barci BM, Webster MJ, Bartko JJ, Meador-Woodruff JH, Knable MB. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol Psychiatry 2005; 57: 252-260
51. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 2004; 9: 734-755